Johnson & Johnson connected to Synthes Swiss pharmaceutical company Roche enjoyed an almost 10 percent rise in third-quarter sales thanks to better than expected demand for Tamiflu which is being bought by governments to treat the H1N1 strain of flu.
Total sales hit 8.2 billion euros helped by its strong position in anti-cancer drugs. Roche has raised its full-year forecast for both overall drug sales and those of Tamiflu.More about: Pharmaceutical companies, SwitzerlandCopyright © 2012 euronews
Top Stories
Greek debt deal sparks protests and a strike
Their political leaders may be breathing a sigh of relief. However, Greeks protesting outside parliament are far from happy that…
Deadly shelling continues in Homs
In Syria, the heavy bombardment of opposition-held neighbourhoods in Homs is reportedly…
Spain's 'human rights' judge Garzón convicted
Spain’s best-known judge, who achieved international fame for his human rights…
Corporate news
Renault’s low-cost Moroccan factory upsets politicians- Pepsi cuts jobs, boosts marketing chasing Coke
- Southern Europe hanging up on Vodafone
- Some shareholders baulk at Glencore-Xstrata merger
- Upbeat forecast from Toyota
- Gloomy outlook from UBS
- Boeing plays down 787 delamination problem
- Mitsubishi puts the brakes on European production
- Panasonic joins Sony and Sharp in sea of red ink
- Debt grounds Hungary’s Malev
euronews on facebook
